
FDA Panel Recommends Loosening Restrictions on Peptides Amid Safety Concerns
An advisory panel from the Food and Drug Administration (FDA) has suggested easing restrictions on various peptides, despite warnings from federal scientists about the limited evidence supporting their safety and effectiveness. Peptides have gained traction among wellness influencers and celebrities, who promote them for their supposed antiaging, anti-inflammatory, and longevity benefits. The panel’s advice could […]





